Endo International PLC (NASDAQ:ENDP) (TSE:ENL) was the recipient of a large decrease in short interest during the month of September. As of September 14th, there was short interest totalling 36,096,754 shares, a decrease of 2.8% from the August 31st total of 37,153,175 shares. Based on an average trading volume of 3,775,438 shares, the short-interest ratio is presently 9.6 days. Approximately 18.0% of the shares of the company are sold short.

In other Endo International news, Director Roger H. Kimmel sold 26,074 shares of the company’s stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $15.90, for a total transaction of $414,576.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.80% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in ENDP. Schroder Investment Management Group grew its holdings in shares of Endo International by 529.4% in the 1st quarter. Schroder Investment Management Group now owns 419,796 shares of the company’s stock worth $2,494,000 after acquiring an additional 353,096 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Endo International by 13.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,446,852 shares of the company’s stock worth $23,074,000 after acquiring an additional 284,599 shares during the period. Sivik Global Healthcare LLC acquired a new stake in shares of Endo International in the 2nd quarter worth approximately $1,697,000. Arizona State Retirement System grew its holdings in shares of Endo International by 115.7% in the 2nd quarter. Arizona State Retirement System now owns 293,200 shares of the company’s stock worth $2,765,000 after acquiring an additional 157,252 shares during the period. Finally, River & Mercantile Asset Management LLP grew its holdings in shares of Endo International by 18.6% in the 2nd quarter. River & Mercantile Asset Management LLP now owns 554,835 shares of the company’s stock worth $5,229,000 after acquiring an additional 87,102 shares during the period. Institutional investors and hedge funds own 98.43% of the company’s stock.

NASDAQ ENDP opened at $16.70 on Friday. The company has a debt-to-equity ratio of -132.64, a quick ratio of 0.91 and a current ratio of 1.07. Endo International has a 12-month low of $5.27 and a 12-month high of $17.46. The company has a market cap of $3.64 billion, a price-to-earnings ratio of 4.35, a price-to-earnings-growth ratio of 3.12 and a beta of 0.74.

Endo International (NASDAQ:ENDP) (TSE:ENL) last released its earnings results on Wednesday, August 8th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.22. Endo International had a positive return on equity of 237.45% and a negative net margin of 34.72%. The company had revenue of $714.70 million for the quarter, compared to analysts’ expectations of $679.72 million. During the same quarter in the previous year, the firm posted $0.93 EPS. The firm’s quarterly revenue was down 18.4% on a year-over-year basis. equities research analysts forecast that Endo International will post 2.6 EPS for the current year.

Several analysts have commented on the company. Zacks Investment Research raised Endo International from a “hold” rating to a “buy” rating and set a $18.00 price objective for the company in a research note on Monday. BidaskClub raised Endo International from a “hold” rating to a “buy” rating in a research note on Thursday, June 21st. Deutsche Bank set a $11.00 price objective on Endo International and gave the company a “buy” rating in a research note on Wednesday, July 18th. Stifel Nicolaus upped their price objective on Endo International from $10.00 to $17.00 and gave the company a “hold” rating in a research note on Thursday, August 9th. Finally, BMO Capital Markets boosted their target price on Endo International from $9.00 to $16.00 and gave the stock a “market perform” rating in a research report on Friday, August 10th. They noted that the move was a valuation call. Fifteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $14.55.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Featured Story: What strategies should day traders use to execute a trade?

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.